First Trust Capital Management’s Eucrates Biomedical Acquisition Corp. Ordinary Shares EUCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-208,598
| Closed | -$2.09M | – | 395 |
|
|
2022
Q3 | $2.09M | Buy |
208,598
+38,740
| +23% | +$388K | 0.1% | 249 |
|
|
2022
Q2 | $1.68M | Buy |
169,858
+2,333
| +1% | +$23.1K | 0.12% | 203 |
|
|
2022
Q1 | $1.65M | Hold |
167,525
| – | – | 0.18% | 112 |
|
|
2021
Q4 | $1.64M | Hold |
167,525
| – | – | 0.29% | 95 |
|
|
2021
Q3 | $1.64M | Buy |
167,525
+100
| +0.1% | +$978 | 0.25% | 101 |
|
|
2021
Q2 | $1.65M | Buy |
+167,425
| New | +$1.65M | 0.25% | 92 |
|